Related Experiment Video
Updated: Mar 24, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Updates in pediatric kidney transplantation
1University of Wisconsin Madison, Madison, Wisconsin, USA.
Insights
Pediatric kidney transplant research shows improved outcomes with nonideal donor organs and highlights potential benefits of thromboprophylaxis and new immunosuppression drugs. Further studies are needed to optimize these strategies for children.
Area of Science:
- Pediatric Nephrology
- Transplant Medicine
- Immunosuppression
Background:
- Dialysis in children carries long-term risks.
- Utilizing 'nonideal' donor kidneys in pediatric transplantation shows promise.
- Emerging research focuses on optimizing post-transplant care.
Purpose of the Study:
- To review recent pediatric nephrology research relevant to clinical practice.
- To highlight advancements in pediatric kidney transplantation.
- To inform clinical decision-making in pediatric nephrology.
Main Methods:
- Review of recent registry data.
- Analysis of observational studies on donor kidney utilization.
- Evaluation of emerging immunosuppression and prophylaxis agents.
Main Results:
- Limited dialysis exposure in children has long-term adverse effects.
- Positive outcomes observed with 'nonideal' donor kidneys in pediatric patients.
- Thromboprophylaxis and aggressive fluid management show potential post-transplant benefits.
- Belatacept and letermovir are promising alternatives for immunosuppression and CMV prophylaxis.
Conclusions:
- Consider a wider range of donor organs for select pediatric transplant recipients.
- Further interventional research is required for peritransplant thromboprophylaxis and fluid management.
- Ongoing trials of belatacept and letermovir may significantly change post-transplant care standards.
Purpose Of Review:
This manuscript highlights key areas of recent pediatric nephrology research that may be relevant to clinical practice.
Recent Findings:
Recent reviews of registry data have emphasized the long-term harms of even limited dialysis exposure in children, while studies of 'nonideal' donor kidneys in children have shown positive outcomes. New observational research suggests a benefit to thromboprophylaxis and aggressive fluid management immediately posttransplant, though the best prescriptions remain unclear. Belatacept and letermovir are emerging options for immunosuppression and CMV prophylaxis, respectively, that may have fewer side effects compared to standard of care; interventional studies of these drugs are ongoing.
Conclusion:
Transplant teams should consider using a broader range of donor organs in select pediatric patients. Further interventional research on peritransplant thromboprophylaxis and fluid management is needed to optimize management strategies. The completion of ongoing belatacept and letermovir trials have the potential to substantially alter posttransplant standards of care.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

